Neurological Numbness and tingling (especially in the hands and feet), headaches, migraines tics, tremors, pseudo-seizures, true seizures, waxing and waning brain fog, memory loss, poor concentration, difficulty finding words, and spells of cataplexy (suddenly becoming disconnected from and unresponsive or unreactive to the world around)
And so there are people who take Kispeptin peptides as a way to stimulate these pathways
An antihypertensive earning $3 billion annually in the adult market gets six months of additional market protection worth roughly $1.5 billion in exchange for a pediatric study that might cost $20-50 million
Introducing retatrutide Retatrutide, also known as LY3437943, is a novel triple-hormone receptor agonist that targets the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors
The dose schedule typically begins at 1 mg weekly, titrating up to 8-12 mg over several weeks